INmune Bio, Inc

(NASDAQ:INMB)

Latest On INmune Bio, Inc (INMB):

Date/Time Type Description Signal Details
2023-05-08 11:51 ESTNewsINmune Bio gets FDA IND approval for prostate cancer immunotherapyN/A
2023-05-04 00:56 ESTNewsINmune Bio GAAP EPS of -$0.36N/A
2023-05-04 00:55 ESTNewsINmune Bio, Inc. (INMB) Q1 2023 Earnings Call TranscriptN/A
2023-04-24 07:21 ESTNewsINmune Bio: Alzheimer's Disease Treatment Lottery TicketN/A
2023-04-03 22:50 ESTNewsINmune rises 7% after company files application to begin trial of cancer treatmentN/A
2023-03-03 08:05 ESTNewsINmune Bio, Inc. (INMB) Q4 2022 Earnings Call TranscriptN/A
2023-03-02 17:57 ESTNewsINmune Bio GAAP EPS of -$1.52 beats by $0.14, revenue of $0.37M beats by $0.17MN/A
2023-03-02 03:13 ESTNewsINmune Bio FY 2022 Earnings PreviewN/A
2023-02-08 22:42 ESTNewsINmune Bio to fund Alzheimer’s trial with over $6M R&D rebatesN/A
2023-01-05 10:19 ESTNewsINmune Bio: INKmune For Solid Tumors And Other Potential CatalystsN/A
2022-11-22 21:57 ESTNewsINmune Bio, High Risk, Higher RewardN/A
2022-11-22 03:40 ESTNewsINmune Bio, High Risk, Higher Reward.N/A
2022-11-14 10:27 ESTNewsINmune receives green signal from Canada to begin trial of XPro1595 in mild Alzheimer’s DiseaseN/A
2022-11-04 04:11 ESTNewsINmune Bio, Inc. (INMB) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 18:55 ESTNewsINmune Bio GAAP EPS of -$0.43N/A
2022-11-02 03:01 ESTNewsINmune Bio Q3 2022 Earnings PreviewN/A
2022-08-03 22:07 ESTNewsINmune Bio GAAP EPS of -$0.38N/A
2022-08-03 22:07 ESTNewsINmune Bio, Inc's (INMB) CEO RJ Tesi on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 07:18 ESTNewsINmune Bio Q2 2022 Earnings PreviewN/A
2022-06-22 21:25 ESTNewsINmune Bio gets US patent covering use of XPro for neurological disordersN/A
2022-05-25 18:53 ESTNewsINmune Bio: Possibly The Once In A Lifetime DipN/A
2022-05-24 20:43 ESTNewsINmune Bio down 22% on Alzheimer's candidate mid-stage trial holdN/A
2022-05-23 22:31 ESTNewsINmune says FDA put on hold application to start phase 2 trial of Alzheimer's treatmentN/A
2022-05-08 17:53 ESTNewsINmune Bio's (INMB) CEO RJ Tesi on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-06 04:08 ESTNewsINmune Bio GAAP EPS of -$0.39, revenue of $0.2MN/A
2022-05-05 04:57 ESTNewsINmune Bio Q1 2022 Earnings PreviewN/A
2022-04-13 18:54 ESTNewsINmune starts dosing in phase 2 XPro1595 trial to treat neuroinflammation due to Alzheimer’sN/A
2022-04-05 10:20 ESTNewsINmune Bio: Speculative Biotech With 2 Solid Potential Approaches To Treating AD And Solid TumorsN/A
2022-03-04 06:45 ESTNewsINmune Bio GAAP EPS of -$1.88 misses by $1.30, revenue of $0.18MN/A
2022-03-04 06:44 ESTNewsINmune Bio, Inc. (INMB) CEO Raymond J. Tesi on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-17 15:18 ESTNewsINmune Bio, The Biotech In My Stable For After Cassava SciencesN/A
2021-12-03 15:54 ESTNewsWarning: INMB is at high risk of performing badlyN/A
2021-11-04 11:05 ESTNewsINmune Bio, Inc. (INMB) CEO R. J. Tesi on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-02 17:58 ESTNewsINmune Bio Q3 2021 Earnings PreviewN/A
2021-10-13 23:24 ESTNewsINmune Bio A No-Brainer InvestmentN/A
2021-09-09 06:27 ESTNewsINmune slides 20% following 192.5K share offering from XencorN/A
2021-09-02 21:16 ESTNewsINmune Bio jumps 11% after XPro data in Alzheimer’s diseaseN/A
2021-08-18 11:30 ESTNewsINmune Bio: High-Risk High-Reward Alzheimer's PlayN/A
2021-08-12 19:07 ESTNewsOur Bullish Take On INmune Bio's Drug PipelineN/A
2021-08-08 14:03 ESTNewsINmune Bio, Inc. (INMB) CEO David Moss on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 06:48 ESTNewsINmune Bio EPS misses by $0.10N/A
2021-07-26 17:55 ESTNewsINMune releases design for phase 2 trial of Alzheimer's candidate XPro1595N/A
2021-07-23 01:31 ESTNewsINmune Bio acquires LUMICKS' z-Movi Cell Avidity AnalyzerN/A
2021-07-21 12:41 ESTNewsINmune enters $15M credit facility to fund purchase of Xencor optionN/A
2021-07-21 12:27 ESTNewsCassava, Annovis, and INmune PTs raised at Maxim on aducanumab approvalN/A
2021-07-21 12:26 ESTNewsINmune Bio surges ahead of key data readoutN/A
2021-07-21 12:25 ESTNewsINmune treats first patient in early-stage INKmune MDS studyN/A
2021-07-21 12:24 ESTNewsINmune Bio: Underfollowed AD Player With Very Bullish August MomentumN/A
2021-07-21 12:24 ESTNewsINmune Bio under pressure on launch of $40M direct offeringN/A
2021-05-06 14:04 ESTNewsINmune Bio, Inc. (INMB) CEO RJ Tesi on Q1 2021 Results - Earnings Call TranscriptN/A

About INmune Bio, Inc (INMB):

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer Alzheimer's disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03 that treats patients with advanced cancers with elevated biomarkers of inflammation in their blood; XPro1595 for the treatment of Alzheimer's disease; LivNate to treat patients with non-alcoholic steatohepatitis; and Quellor for cytokine release syndrome and complications of COVID-19. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in La Jolla, California.

INMB Quotes by TradingView

See Advanced Chart

General

  • Name INmune Bio, Inc
  • Symbol INMB
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 5
  • Fiscal Year EndDecember
  • IPO Date2019-02-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.inmunebio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15957.57
  • Price/Book (Most Recent Quarter) 5.6
  • Enterprise Value Revenue 17878.76
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$1.87
  • Next Quarter EPS Estimate -$0.38
  • Operating Margin -112016%
  • Return on Assets -23%
  • Return on Equity -39%
  • Revenue 10916
  • Earnings Per Share -$0.62
  • Revenue Per Share $0
  • Gross Profit 10916
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 222.05 million
  • PE Ratio -3.47
  • Analyst Target Price $29.67
  • Book Value Per Share $2.88
View More

Share Statistics

  • Shares Outstanding 14.93 million
  • Shares Float 8.87 million
  • % Held by Insiders 4507%
  • % Held by Institutions 12.61%
  • Shares Short 364561
  • Shares Short Prior Month 447423
  • Short Ratio 1.11
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 2.96
  • 52 Week High $29.99
  • 52 Week Low $2.22
  • 50 Day Moving Average 17.86
  • 200 Day Moving Average 13.14
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

INmune Bio, Inc (INMB) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

INmune Bio, Inc (INMB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$10916-$0.26-$0.3115.45%
2020-09-302020-11-05$N/A-$0.36-$0.17-108.7%
2020-06-302020-08-05$N/A-$0.20-$0.2313.04%
2020-03-312020-05-14$N/A-$0.19-$0.219.52%
2019-12-312020-03-11$N/A-$0.22-$0.247.37%
2019-09-302019-11-08$N/A-$0.28-$0.19-44.85%
2019-06-302019-08-09$N/A-$0.04-$0.2080%
2019-03-312019-05-15$N/A-$0.20-$0.19-5.26%
2018-12-312019-03-29$N/A-$0.21-$0.19-10.53%

INmune Bio, Inc (INMB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

INmune Bio, Inc (INMB) Chart:

INmune Bio, Inc (INMB) News:

Below you will find a list of latest news for INmune Bio, Inc (INMB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

INmune Bio, Inc (INMB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-06-180.50CALL0 40TRUE00
2026-06-1810CALL0 45256.75TRUE00
2026-06-181.50.07CALL0 72775.85FALSE00
2026-06-1820.03CALL0 2226135.4FALSE00
2026-06-1830.05CALL0 1504227.85FALSE00
2026-06-1840CALL0 59285.84FALSE00
2026-06-1850.05CALL1 19807.22FALSE0.050
2026-06-180.50.04PUT0 4619.54FALSE00
2026-06-1810PUT0 9306.65FALSE00
2026-06-181.50.31PUT0 1091.06TRUE00
2026-06-1820.53PUT0 240TRUE00
2026-06-1831.57PUT0 57259.66TRUE00
2026-06-1840PUT0 250TRUE00
2026-06-1850PUT0 00TRUE00
2026-07-1710CALL0 0154.68TRUE00
2026-07-1720.09CALL0 10101.69FALSE00
2026-07-1730CALL0 0349.78FALSE00
2026-07-1740CALL0 0458.34FALSE00
2026-07-1750CALL0 0490.31FALSE00
2026-07-1710PUT0 0349.54FALSE00
2026-07-1720.6PUT30 00TRUE0.60
2026-07-1730PUT0 0162.58TRUE00
2026-07-1740PUT0 0243.05TRUE00
2026-07-1750PUT0 0274.25TRUE00
2026-09-1810.56CALL0 296352.65TRUE00
2026-09-1820.35CALL0 377145.97FALSE00
2026-09-1830.24CALL2 463243.08FALSE0.10.71
2026-09-1840CALL0 3288.8FALSE00
2026-09-1850CALL0 0317.95FALSE00
2026-09-1810PUT0 18228.74FALSE00
2026-09-1820.92PUT0 224173.49TRUE00
2026-09-1830PUT0 12189.94TRUE00
2026-09-1840PUT0 1164.02TRUE00
2026-09-1850PUT0 72225.8TRUE00
2026-12-1810.45CALL0 199123.29TRUE00
2026-12-1820.35CALL0 178143.6FALSE00
2026-12-1830.25CALL0 165116.39FALSE00
2026-12-1840CALL0 0218.67FALSE00
2026-12-1850.12CALL0 40259.06FALSE00
2026-12-1810PUT0 0219.07FALSE00
2026-12-1820PUT0 0168.62TRUE00
2026-12-1830PUT0 49156.87TRUE00
2026-12-1840PUT0 0127.1TRUE00
2026-12-1850PUT0 0173.46TRUE00

Latest INMB Trades:

Date Shares Price
Jun 13, 2022 7:46 PM EST120$6.635
Jun 13, 2022 7:50 PM EST100$6.62
Jun 13, 2022 7:51 PM EST60$6.605
Jun 13, 2022 7:55 PM EST365$6.62
Jun 13, 2022 7:56 PM EST10$6.62

INmune Bio, Inc (INMB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020014985/0001213900-20-014985-index.htm
2019-06-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711754/000000000019010444/0000000000-19-010444-index.htm
2019-07-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711754/000000000019011485/0000000000-19-011485-index.htm
2020-03-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711754/000000000020002785/0000000000-20-002785-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000110465920008253/0001104659-20-008253-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711754/000110465920021049/0001104659-20-021049-index.htm
2019-02-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000120919119008770/0001209191-19-008770-index.htm
2019-02-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000120919119008772/0001209191-19-008772-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/0001213900-19-015380-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019015549/0001213900-19-015549-index.htm
2019-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016070/0001213900-19-016070-index.htm
2019-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016187/0001213900-19-016187-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016514/0001213900-19-016514-index.htm
2019-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016813/0001213900-19-016813-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017204/0001213900-19-017204-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017510/0001213900-19-017510-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017870/0001213900-19-017870-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017874/0001213900-19-017874-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017904/0001213900-19-017904-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019018359/0001213900-19-018359-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019018683/0001213900-19-018683-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019019236/0001213900-19-019236-index.htm
2019-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019019987/0001213900-19-019987-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019020655/0001213900-19-020655-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000121390019022556/0001213900-19-022556-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019022948/0001213900-19-022948-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024216/0001213900-19-024216-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024949/0001213900-19-024949-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024951/0001213900-19-024951-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024954/0001213900-19-024954-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024956/0001213900-19-024956-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024961/0001213900-19-024961-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024968/0001213900-19-024968-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024971/0001213900-19-024971-index.htm
2019-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019025038/0001213900-19-025038-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019025204/0001213900-19-025204-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019026351/0001213900-19-026351-index.htm
2020-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020000044/0001213900-20-000044-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390020000646/0001213900-20-000646-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020000847/0001213900-20-000847-index.htm
2020-01-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020001935/0001213900-20-001935-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020003050/0001213900-20-003050-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000121390020003972/0001213900-20-003972-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000121390020003973/0001213900-20-003973-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000121390020003974/0001213900-20-003974-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020005391/0001213900-20-005391-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020005786/0001213900-20-005786-index.htm
2020-03-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1711754/000121390020005916/0001213900-20-005916-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020006109/0001213900-20-006109-index.htm
2020-03-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711754/000121390020007264/0001213900-20-007264-index.htm
2020-03-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711754/000121390020008226/0001213900-20-008226-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020008917/0001213900-20-008917-index.htm
2020-04-14POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009194/0001213900-20-009194-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009372/0001213900-20-009372-index.htm
2020-04-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020009374/0001213900-20-009374-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009642/0001213900-20-009642-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009707/0001213900-20-009707-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009822/0001213900-20-009822-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009925/0001213900-20-009925-index.htm
2020-04-24424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020010039/0001213900-20-010039-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020010301/0001213900-20-010301-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020010962/0001213900-20-010962-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020011278/0001213900-20-011278-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020011855/0001213900-20-011855-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020012056/0001213900-20-012056-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020012422/0001213900-20-012422-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020012725/0001213900-20-012725-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020013101/0001213900-20-013101-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020014985/0001213900-20-014985-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020017207/0001213900-20-017207-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020017343/0001213900-20-017343-index.htm
2020-07-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020017565/0001213900-20-017565-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020017615/0001213900-20-017615-index.htm
2020-07-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020017634/0001213900-20-017634-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020017924/0001213900-20-017924-index.htm
2020-07-218-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020018013/0001213900-20-018013-index.htm
2020-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020018871/0001213900-20-018871-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020019177/0001213900-20-019177-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020019888/0001213900-20-019888-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020020373/0001213900-20-020373-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020020662/0001213900-20-020662-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020020897/0001213900-20-020897-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020022288/0001213900-20-022288-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020022769/0001213900-20-022769-index.htm
2020-08-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020022773/0001213900-20-022773-index.htm
2020-08-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1711754/000121390020023303/0001213900-20-023303-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020025123/0001213900-20-025123-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020025397/0001213900-20-025397-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020026558/0001213900-20-026558-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020027055/0001213900-20-027055-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020028229/0001213900-20-028229-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020028780/0001213900-20-028780-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020029548/0001213900-20-029548-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020030205/0001213900-20-030205-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020033364/0001213900-20-033364-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020035280/0001213900-20-035280-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020035449/0001213900-20-035449-index.htm
2019-02-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000218/0001640334-19-000218-index.htm
2019-02-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000219/0001640334-19-000219-index.htm
2019-02-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000220/0001640334-19-000220-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000238/0001640334-19-000238-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000337/0001640334-19-000337-index.htm
2019-03-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000350/0001640334-19-000350-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000374/0001640334-19-000374-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1711754/000164033419000466/0001640334-19-000466-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000543/0001640334-19-000543-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000577/0001640334-19-000577-index.htm
2019-04-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000661/0001640334-19-000661-index.htm
2019-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000708/0001640334-19-000708-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000755/0001640334-19-000755-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000758/0001640334-19-000758-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000761/0001640334-19-000761-index.htm
2019-05-094/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000793/0001640334-19-000793-index.htm
2019-05-10DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000800/0001640334-19-000800-index.htm
2019-05-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000817/0001640334-19-000817-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000820/0001640334-19-000820-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000834/0001640334-19-000834-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000164033419000853/0001640334-19-000853-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000899/0001640334-19-000899-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000911/0001640334-19-000911-index.htm
2019-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000940/0001640334-19-000940-index.htm
2019-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000942/0001640334-19-000942-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000971/0001640334-19-000971-index.htm
2019-05-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000974/0001640334-19-000974-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000996/0001640334-19-000996-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001033/0001640334-19-001033-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001035/0001640334-19-001035-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001039/0001640334-19-001039-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001049/0001640334-19-001049-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001052/0001640334-19-001052-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001070/0001640334-19-001070-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001099/0001640334-19-001099-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001161/0001640334-19-001161-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001172/0001640334-19-001172-index.htm
2019-06-21S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711754/000164033419001189/0001640334-19-001189-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001220/0001640334-19-001220-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001240/0001640334-19-001240-index.htm
2019-06-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001254/0001640334-19-001254-index.htm
2019-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001259/0001640334-19-001259-index.htm
2019-07-03424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711754/000164033419001285/0001640334-19-001285-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001293/0001640334-19-001293-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001309/0001640334-19-001309-index.htm
2019-07-18S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711754/000164033419001410/0001640334-19-001410-index.htm
2019-07-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001451/0001640334-19-001451-index.htm
2019-07-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711754/000164033419001474/0001640334-19-001474-index.htm
2019-07-29PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001480/0001640334-19-001480-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001494/0001640334-19-001494-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001511/0001640334-19-001511-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001540/0001640334-19-001540-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000164033419001563/0001640334-19-001563-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001566/0001640334-19-001566-index.htm
2019-08-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001577/0001640334-19-001577-index.htm
2019-07-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711754/999999999519001521/9999999995-19-001521-index.htm
2019-07-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711754/999999999519001719/9999999995-19-001719-index.htm
2020-04-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711754/999999999520000673/9999999995-20-000673-index.htm
2020-04-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711754/999999999520000788/9999999995-20-000788-index.htm

INmune Bio, Inc (INMB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of INmune Bio, Inc (INMB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 4507%
Institutional Ownership: 1261%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-08-06:00Linda F Powers10% Share HolderBuy61,667.009.00555,003.001,120,000.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419000820/0001640334-19-000820-index.htm
2019-06-03-06:00Linda F Powers10% Share HolderBuy10,000.006.0060,000.001,130,000.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419001052/0001640334-19-001052-index.htm
2019-05-06-06:00David J MossCFO, Treasurer & SecretaryBuy5,000.009.0045,000.001,210,417.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419000761/0001640334-19-000761-index.htm
2019-06-03-06:00David J MossCFO, Treasurer & SecretaryBuy10,000.006.0060,000.001,220,417.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419001035/0001640334-19-001035-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy77.005.65435.051,220,494.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy239.005.651,350.351,220,733.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy2,000.005.6511,300.001,222,733.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy72.005.65406.801,222,805.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy236.005.651,333.401,223,041.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy376.005.652,124.401,223,417.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-09-11Mark William LowdellChief Scientific OfficerBuy2,918.006.2318,178.561,506,251.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019017904/0001213900-19-017904-index.htm
2019-05-02-06:00Raymond Joseph TesiChairmanBuy11,100.009.90109,890.001,526,933.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419000758/0001640334-19-000758-index.htm
2019-06-03-06:00Raymond Joseph TesiPresident & CEOBuy10,000.006.0060,000.001,536,933.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419001033/0001640334-19-001033-index.htm
2019-08-09Raymond Joseph TesiPresident & CEOBuy100.007.20720.001,537,033.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/0001213900-19-015380-index.htm
2019-08-09Raymond Joseph TesiPresident & CEOBuy900.007.146,428.791,537,933.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/0001213900-19-015380-index.htm
2019-08-09Raymond Joseph TesiPresident & CEOBuy1,000.006.916,909.501,538,933.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/0001213900-19-015380-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,033.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,133.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,233.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,333.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,433.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,533.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,633.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,733.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,833.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.92592.391,539,933.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy1,000.006.036,030.801,540,933.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2020-01-27Linda F Powers10% Share HolderSell220,000.004.601,012,000.00210,000.00https://www.sec.gov/Archives/edgar/data/1711754/000110465920008253/0001104659-20-008253-index.htm
2019-06-03-06:00Scott JudaDirectorBuy10,000.006.0060,000.0022,500.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419001039/0001640334-19-001039-index.htm
2019-08-20Scott JudaDirectorBuy2,500.006.0015,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016514/0001213900-19-016514-index.htm
2019-08-21Scott JudaDirectorBuy2,500.006.0015,000.0027,500.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016514/0001213900-19-016514-index.htm